Coronavirus Update: U.S. appears set to tighten test requirements for travelers
- ByMarketWatch-
Coronavirus Update: U.S. appears set to tighten test requirements for travelers
Coronavirus Update: U.S. appears set to tighten test requirements for travelers
The U.S. is planning to beef up testing requirements for international travelers entering the country in the light of the new omicron variant of the coronavirus that causes...
It’s likely that Merck’s COVID-19 pill will be authorized in the U.S. this month but it's expected to be restricted to certain high-risk people.
FDA Advisory Committee Narrowly Votes To Approve Merck's COVID 'Miracle Drug'During a week that has seen a new COVID variant emerge and suddenly throw the efficacy of American...
Los Angeles, USA, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Renal Cell Carcinoma Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsightThere are around 80+ key companies...
It hopes to make the drug available in poor countries as well as rich ones
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases. The company also provides life science products and services, including research, process, and applied solution. In addition, it offers specialty chemicals for semiconductor, liquid crystals, organic light-emitting diodes, effect pigments, automotive, and functional solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Novartis AG and Vera Therapeutics, Inc.; and collaboration with F-star Delta Ltd., Artios Pharma Limited, CytoReason, and Inbrain Neuroelectronics S.L. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Strong Sell | Neutral | Strong Buy |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Neutral | Strong Sell | Strong Sell | Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 163.21 | 163.98 | 157.80 | -1.56 | -0.95% | 107.49M | NASDAQ | |||
| 309.52 | 314.59 | 307.20 | -1.08 | -0.35% | 18.25M | NASDAQ | |||
| 2,869.30 | 2,869.30 | 2,805.00 | +48.3 | +1.71% | 908.77K | NASDAQ | |||
| 35.38 | 39.68 | 34.02 | -2.93 | -7.65% | 71.12M | NYSE | |||
| 120.56 | 125.00 | 119.36 | -1.93 | -1.58% | 25.27M | NYSE | |||
| 321.52 | 324.77 | 310.33 | +7.17 | +2.28% | 35.87M | NASDAQ | |||
| 18.16 | 18.38 | 17.94 | -0.23 | -1.25% | 18.85M | NYSE | |||
| 186.29 | 188.80 | 179.75 | +6.97 | +3.89% | 14.84M | NASDAQ | |||
| 3,436.04 | 3,491.00 | 3,426.98 | -7.68 | -0.22% | 2.31M | NASDAQ | |||
| 10.39 | 10.47 | 9.59 | +0.93 | +9.81% | 38.34M | NYSE | |||
| 5.79 | 5.835 | 5.70 | -0.030 | -0.52% | 11.69M | NYSE | |||
| 24.25 | 24.29 | 23.13 | +0.76 | +3.23% | 12.42M | NYSE | |||
| 0.2391 | 0.00 | 0.00 | -0.0019 | -0.79% | 4.04M | NYSE | |||
| 616.60 | 624.25 | 612.89 | -1.17 | -0.19% | 2.00M | NASDAQ | |||
| 10.94 | 11.27 | 10.78 | -0.23 | -2.06% | 4.69M | NYSE |